319
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Robust classification-based molecular modelling of diverse chemical entities as potential SARS-CoV-2 3CLpro inhibitors: theoretical justification in light of experimental evidences

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 473-493 | Received 31 Jan 2021, Accepted 06 Apr 2021, Published online: 20 May 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Suvankar Banerjee, Shristi Kejriwal, Balaram Ghosh, Goverdhan Lanka, Tarun Jha & Nilanjan Adhikari. (2023) Fragment-based investigation of thiourea derivatives as VEGFR-2 inhibitors: a cross-validated approach of ligand-based and structure-based molecular modeling studies. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-17.
Read now
S. Banerjee, S.K. Baidya, B. Ghosh, T. Jha & N. Adhikari. (2023) Exploration of structural alerts and fingerprints for novel anticancer therapeutics: a robust classification-QSAR dependent structural analysis of drug-like MMP-9 inhibitors. SAR and QSAR in Environmental Research 34:4, pages 299-319.
Read now
B. Sepehri, R. Ghavami, F. Mahmoudi, M. Irani, R. Ahmadi & D. Moradi. (2022) Identifying SARS-CoV-2 main protease inhibitors by applying the computer screening of a large database of molecules. SAR and QSAR in Environmental Research 33:5, pages 341-356.
Read now
S.M. Medvedeva, K.S. Shikhaliev, A.A. Geronikaki, P.I. Savosina, D.S. Druzhilovskiy & V.V. Poroikov. (2022) Computer-aided discovery of pleiotropic effects: Anti-inflammatory action of dithioloquinolinethiones as a case study. SAR and QSAR in Environmental Research 33:4, pages 273-287.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.